JBS NV Ordinary Shares - (JBS) Earnings Date & Reports
JBS NV is a protein food company, selling protein products, which include fresh and frozen cuts of beef, pork, lamb, fish, whole chickens, and chicken parts, to retailers, and foodservice companies... Show more
JBS is expected to report earnings to rise 72.29% to 36 cents per share on August 10
JBS N.V. (JBS) Q1 2026 Earnings Recap: Profit Plunges on U.S. Beef Woes
Key Takeaways
- JBS N.V. reported Q1 2026 net revenue of $21.6 billion, up 11% year-over-year, beating consensus estimates slightly.
- Net income fell 56% to $221 million, missing analyst expectations of $236 million, with diluted EPS at $0.20 versus estimates around $0.24-$0.28.
- Adjusted EBITDA dropped 26% to $1.13 billion (5.2% margin), below forecasts of $1.27 billion, pressured by North American operations.
- Beef North America posted negative EBITDA of -$230 million (-3.2% margin) due to low cattle supply and high procurement costs.
- Brazil beef and Seara operations provided offsets with strong export demand and consistent performance.
- Leverage at 2.77x net debt/EBITDA (earnings before interest, taxes, depreciation, and amortization), ROE (return on equity) at 22.1%.
Earnings Context and Why It Matters
As the world's largest meatpacker by capacity, JBS N.V. faces intense scrutiny on its ability to navigate commodity cycles and regional disparities. Q1 2026 results highlight vulnerabilities in its key U.S. beef segment amid a tight cattle supply, contrasting with robust global demand for Brazilian exports. This earnings report matters for investors tracking protein sector dynamics, supply chain resilience, and the company's multi-geography strategy. With shares recently listing on NYSE, results test market confidence in JBS's diversification across beef, pork, and poultry amid inflation and weather disruptions.
JBS N.V. released Q1 2026 results (period ended March 31, 2026) on May 12, showing net revenue of $21.6 billion, up 11% from $19.5 billion in Q1 2025 and above consensus of ~$21.5 billion. Net income attributable to shareholders dropped to $221 million from ~$500 million last year, with diluted EPS of $0.20 missing estimates of $0.24-$0.28. Adjusted EBITDA fell to $1.13 billion from $1.53 billion, margin contracting to 5.2%.+Releases+Q1+2026+Earnings:+Revenue+Beats,+EPS+Miss+and+Net+Income+Falls)
Beef North America revenue hit $7.17 billion (up ~12%) but EBITDA was negative $230 million (-3.2% margin), hit by cattle shortages, high prices, plant strikes, and poultry issues at Pilgrim's Pride. Brazil beef EBITDA rose 28% to $168 million on record $3.79 billion sales, fueled by exports. Seara sustained strength domestically and abroad. Operating profit declined sharply to $484.5 million. Leverage held at 2.77x, ROE 22.1%.
AI Screener
Tickeron’s AI Screener is an AI-powered stock and ETF discovery tool that helps traders and investors filter the market based on technical patterns, fundamentals, trends, volatility, and AI-driven signals. Users can scan thousands of stocks and ETFs using customizable filters such as industry, market capitalization, technical indicators, price patterns, and performance metrics. The screener identifies trade ideas, trending stocks, breakout candidates, and market opportunities more efficiently than manual screening. Explore it today to enhance your research process.
Market Reaction and Investor Sentiment
Post-earnings on May 12, JBS shares closed down ~2% at $15.28, extending to -3.2% in after-hours, reflecting disappointment over profit misses despite revenue beat. Sentiment soured on U.S. beef losses and EBITDA shortfalls, though analysts maintain Buy ratings with targets ~$21, citing diversification. Pre-earnings caution had trimmed EPS estimates 24% in 60 days.
Forward Outlook and Key Factors to Monitor
Investors should watch JBS's execution in recovering U.S. beef margins as cattle cycles evolve. Low supply drove Q1 pain, but gradual herd rebuilding could ease procurement costs later in 2026.
Brazil and Seara remain bright spots; track export volumes amid global protein demand. Poultry at Pilgrim's Pride faces weather and operational risks—monitor production stability.
Adjusted EBITDA margin recovery to historical 7-8% levels hinges on cost discipline and pricing power. Leverage at 2.77x supports flexibility, with long debt maturities (average 15.6 years) and CapEx up 20% for expansion.
Upcoming Q2 earnings on August 13 will reveal if offsets from diversified operations persist amid volatility. Broader factors: commodity prices, currency (BRL/USD), and trade policies.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
Advertisement